Parallel Advisors LLC Increases Stock Holdings in Sabra Healthcare REIT, Inc. $SBRA

Parallel Advisors LLC lifted its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 7.0% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 17,477 shares of the real estate investment trust’s stock after purchasing an additional 1,146 shares during the quarter. Parallel Advisors LLC’s holdings in Sabra Healthcare REIT were worth $322,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently added to or reduced their stakes in the company. Swedbank AB purchased a new position in Sabra Healthcare REIT in the first quarter valued at approximately $19,336,000. Voya Investment Management LLC increased its stake in Sabra Healthcare REIT by 13.4% in the first quarter. Voya Investment Management LLC now owns 422,477 shares of the real estate investment trust’s stock valued at $7,381,000 after purchasing an additional 49,884 shares during the last quarter. Strs Ohio purchased a new position in Sabra Healthcare REIT in the first quarter valued at approximately $777,000. Advisors Capital Management LLC increased its stake in Sabra Healthcare REIT by 20.5% in the first quarter. Advisors Capital Management LLC now owns 2,232,609 shares of the real estate investment trust’s stock valued at $39,004,000 after purchasing an additional 380,505 shares during the last quarter. Finally, Intech Investment Management LLC increased its stake in Sabra Healthcare REIT by 8.4% in the first quarter. Intech Investment Management LLC now owns 245,415 shares of the real estate investment trust’s stock valued at $4,287,000 after purchasing an additional 18,915 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on SBRA shares. Scotiabank raised their target price on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a “sector perform” rating in a research report on Monday, June 23rd. JMP Securities raised their target price on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a “market outperform” rating in a research report on Wednesday, August 6th. Truist Financial raised their target price on shares of Sabra Healthcare REIT from $18.00 to $20.00 and gave the stock a “hold” rating in a research report on Tuesday, September 2nd. Wells Fargo & Company raised their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 27th. Finally, BMO Capital Markets raised their target price on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a “market perform” rating in a research report on Monday, August 25th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $20.83.

Sabra Healthcare REIT Stock Down 0.8%

NASDAQ SBRA opened at $18.71 on Friday. The stock has a market cap of $4.49 billion, a PE ratio of 24.62, a P/E/G ratio of 1.49 and a beta of 0.88. Sabra Healthcare REIT, Inc. has a fifty-two week low of $15.60 and a fifty-two week high of $20.03. The business has a 50 day moving average price of $18.73 and a two-hundred day moving average price of $18.05. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.02. The firm had revenue of $189.15 million during the quarter, compared to analysts’ expectations of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.Sabra Healthcare REIT’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.36 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. As a group, sell-side analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Friday, August 15th were issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 6.4%. The ex-dividend date was Friday, August 15th. Sabra Healthcare REIT’s dividend payout ratio is currently 157.89%.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.